CardioGenics Holdings Inc (CGNH)

Market Cap	143.00 -100.0%
Revenue (ttm)	n/a
Net Income	-980.79K
EPS	-0.01
Shares Out	142.86M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	108,100
Open	0.0001
Previous Close	n/a
Day's Range	0.000001 - 0.0001
52-Week Range	0.000001 - 0.0001
Beta	53.82
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About CardioGenics Holdings

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market. Its products include QL Care Analyzer, which is a portable, stand-alone, and automated POC immunoanalyzer; a series of immunoassay tests to enhance the management of patients with cardiovascular diseases; and paramagnetic beads that are used as a solid surface in medical laboratories’ immunoassay testing equipment. The company was formerly known as Jag Media Holdings, Inc. and changed its name to C...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1997
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: CGNH